|
|
|
FATTY ACID BETA DEGRADATION PATHWAY (PW:0000738)
DescriptionThe degradation of fatty acids represents an essential source of energy; a major route is the mitochondrial beta-oxidation pathway. Before beta-oxidation can proceed, fatty acids need to be 'primed' or activated. The formation of fatty acyl-CoA thioesters is catalyzed by acyl-CoA synthetases in a two-step reaction. There are several acyl-CoA synthetases named after their chain length specificity. Once activated, acyl-CoAs need to reach the mitochondrial matrix where the enzymes of the beta-oxidation pathway are located. The acyl-CoAs, particularly the long-chain ones, cannot easily pass the mitochondrial inner membrane; their translocation is made possible by the CPT system. The acyl moiety is transferred from CoA to carnitine by Cpt1 - an integral membrane protein of the outer mitochondrial membrane. Note that Cpt1 is subject to inhibition by malonyl-CoA, the substrate for the fatty acid biosynthetic pathway. The translocase (Slc25a20) facilitates the translocation of acylcarnitine across the mitochondrial inner membrane where Cpt2 catalyzes the transfer of the acyl group from carnitine to CoA. The acyl-CoA thioesters can now undergo beta-oxidation. The beta-oxidation pathway, generally described as a spiral, consists of a [repeating] cycle of four reactions that produces acetyl-CoA and an acyl-CoA that is two carbon shorter. The spiral repeats itself until the entire acyl-CoA has been broken down to acetyl-CoA. In the first reaction, acyl-CoA is dehydrogenated to trans-2-enoyl-CoA by members of the FAD-containing acyl-CoA dehydrogenase family (Acad). The family contains several members named after their chain-length specificity; of these, the long-chain acyl-CoA dehydrogenase may participate in the beta-oxidation of unsaturated fatty acids. The FADH2 produced in the reaction is re-oxidized by transferring electrons from the dehydrogenase to the FAD group of Etf and from there to Etfdh which feeds the electrons into the electron transport chain thus linking the dehydrogenases to the oxidative phosphorylation pathway culminating in ATP synthesis. In the second reaction, 2-trans-enoyl-CoA is reversibly hydrated to 3-hydroxyacyl-CoA by Echs1. 3-hydroxyacyl-CoA undergoes NAD-dependent dehydrogenation to produce 3-ketoacyl-CoA, a reaction catalyzed by Hadh. The last step involves a thiolase-mediated (Acaa2) cleavage of the thioester bond to release acetyl-CoA and an acyl-CoA which is two carbons shorter and enters another round of the spiral. The last three steps of the beta-oxidation of long-chain acyl-CoA esters - the hydratase, dehydrogenase and thiolase reactions - are carried out by a trifunctional enzyme. The protein consists of two subunits: the alpha subunit (Hadha) catalyzes the first two reactions, the beta subunit (Hadhb) catalyzes the third. While the mono-enzymes are soluble matrix proteins, the trifunctional enzyme is associated with the inner mitochondrial membrane. Disorders of beta-oxidation pathway have been associated with several conditions. To see the ontology report for GViewer, annotations and download, click here[Click to see the ontology report for associated GO term - GO:0006635, related Kegg map - map00071] ...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
fatty acid beta degradation pathway
|
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
|
IDA |
18 |
71,587,259 |
71,632,610 |
RGD:2317624 |
RGD |
| G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
|
|
ISS |
2 |
122,562,974 |
122,585,953 |
RGD:2317589 |
RGD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
|
ISS |
9 |
65,613,130 |
65,651,775 |
RGD:2317589 |
RGD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
|
IDA |
9 |
65,613,130 |
65,651,775 |
RGD:2317678 |
RGD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
|
ISS |
2 |
251,866,645 |
251,890,729 |
RGD:2317589 |
RGD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
|
IDA |
2 |
251,866,645 |
251,890,729 |
RGD:2317678 |
RGD |
| G |
Acads |
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
|
ISS |
12 |
42,765,284 |
42,774,528 |
RGD:2317589 |
RGD |
| G |
Acads |
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
|
IDA |
12 |
42,765,284 |
42,774,528 |
RGD:2317678 |
RGD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
|
IMP |
10 |
56,856,233 |
56,861,380 |
RGD:2317683 |
RGD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
|
ISS |
10 |
56,856,233 |
56,861,380 |
RGD:2317589 |
RGD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
|
ISS |
16 |
49,036,892 |
49,081,416 |
RGD:2317576 |
RGD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
|
ISS |
9 |
78,083,239 |
78,106,933 |
RGD:2317576 |
RGD |
| G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
|
|
ISS |
X |
36,168,547 |
36,232,162 |
RGD:2317576 |
RGD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
|
ISS |
1 |
261,554,383 |
261,599,373 |
RGD:2317576 |
RGD |
| G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
|
|
ISS |
10 |
39,729,805 |
39,778,106 |
RGD:2317576 |
RGD |
| G |
Acsm2a |
acyl-CoA synthetase medium-chain family member 2A |
|
|
ISS |
1 |
177,830,613 |
177,869,061 |
RGD:2317576 |
RGD |
| G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
|
|
ISS |
1 |
178,054,386 |
178,081,751 |
RGD:2317576 |
RGD |
| G |
Acsm4 |
acyl-CoA synthetase medium-chain family member 4 |
|
|
ISS |
1 |
177,972,234 |
177,996,687 |
RGD:2317576 |
RGD |
| G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
|
|
ISS |
3 |
141,259,016 |
141,308,871 |
RGD:2317576 |
RGD |
| G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
|
|
ISS |
3 |
146,013,995 |
146,057,119 |
RGD:2317576 |
RGD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
|
TAS |
1 |
205,852,800 |
205,912,972 |
RGD:2317584 |
RGD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
|
ISS |
7 |
127,737,129 |
127,746,179 |
RGD:2317584 |
RGD |
| G |
Cpt2 |
carnitine palmitoyltransferase 2 |
|
|
TAS |
5 |
129,007,685 |
129,025,501 |
RGD:2317584 |
RGD |
| G |
Echs1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
|
|
IMP |
1 |
199,901,585 |
199,910,412 |
RGD:2317616 |
RGD |
| G |
Etfa |
electron-transfer-flavoprotein, alpha polypeptide |
|
|
ISS |
8 |
59,013,798 |
59,072,013 |
RGD:2317589 |
RGD |
| G |
Etfb |
electron-transfer-flavoprotein, beta polypeptide |
|
|
ISS |
1 |
93,820,124 |
93,834,288 |
RGD:2317589 |
RGD |
| G |
Etfdh |
electron-transferring-flavoprotein dehydrogenase |
|
|
ISS |
2 |
171,008,641 |
171,030,692 |
RGD:2317589 |
RGD |
| G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
|
IMP |
2 |
228,698,545 |
228,751,691 |
RGD:2302227 |
RGD |
| G |
Hadha |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
|
ISS |
6 |
26,173,798 |
26,191,433 |
RGD:2317625 |
RGD |
| G |
Hadhb |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
|
ISS |
6 |
26,139,397 |
26,173,428 |
RGD:2317625 |
RGD |
| G |
Slc25a20 |
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
|
|
ISS |
8 |
113,715,211 |
113,737,063 |
RGD:2317584 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the fatty acid beta degradation pathway
|
|
|
|
|
| Acad9 | Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of | | Acadl | Cardiomegaly , Celiac Disease , Hypoglycemia | | Acadm | Maple Syrup Urine Disease , Medium chain acyl CoA dehydrogenase deficiency , Pyruvate Dehydrogenase Complex Deficiency Disease | | Acads | Colorectal Neoplasms , Short chain Acyl CoA dehydrogenase deficiency | | Acadvl | Obesity , Pyruvate Dehydrogenase Complex Deficiency Disease , VLCAD deficiency | | Acsl1 | Insulin Resistance , Obesity , Starvation | |
| Acsl4 | Intellectual Disability , Mental Retardation, X-Linked , Mental Retardation, X-Linked 63 | |
| Acsl6 | Diabetes Mellitus, Experimental , Inflammation , Leukemia | |
| Acsm3 | Colitis, Ulcerative , Glomerulonephritis, IGA , Hypertension , Ocular Hypertension , Overweight | |
|
|
| Cpt1a | Carnitine palmitoyl transferase 1A deficiency , Diabetes Mellitus, Type 2 , Hepatitis C, Chronic , Lipid Metabolism, Inborn Errors , Obesity | |
| Cpt2 | Carnitine Palmitoyltransferase II Deficiency, Infantile , Carnitine Palmitoyltransferase II Deficiency, Late-Onset , Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal , Lipid Metabolism, Inborn Errors , Muscular Diseases | |
| Etfa | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | | Etfb | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | | Etfdh | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | | Hadha | Fatty Liver , Fetal Growth Retardation , LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY , Trifunctional Protein Deficiency | | Hadhb | Acidosis , Acute Kidney Injury , Alzheimer Disease , Mitochondrial Diseases , Pericardial Effusion , Rhabdomyolysis , Trifunctional Protein Deficiency | | Hadh | Diabetes Mellitus, Experimental , Hypoglycemia , Myocardial Infarction , Obesity | | Slc25a20 | Carnitine-Acylcarnitine Translocase Deficiency , Lipid Metabolism, Inborn Errors | |
| Mental Retardation, X-Linked | Acsl4 | | Intellectual Disability | Acsl4 | | Inflammation | Acsl6 | | Fetal Growth Retardation | Hadha | | Obesity | Acadvl , Acsl1 , Cpt1a , Hadh | | Diabetes Mellitus, Type 2 | Cpt1a | | Cardiomegaly | Acadl | | Carnitine palmitoyl transferase 1A deficiency | Cpt1a | | Lipid Metabolism, Inborn Errors | Cpt1a , Cpt2 , Slc25a20 | | Hypoglycemia | Acadl , Hadh | | Muscular Diseases | Cpt2 | | Maple Syrup Urine Disease | Acadm | | Fatty Liver | Hadha | | Medium chain acyl CoA dehydrogenase deficiency | Acadm | | Acute Kidney Injury | Hadhb | | Pyruvate Dehydrogenase Complex Deficiency Disease | Acadm , Acadvl | | Mitochondrial Diseases | Hadhb | | Colitis, Ulcerative | Acsm3 | | VLCAD deficiency | Acadvl | | Alzheimer Disease | Hadhb | | Leukemia | Acsl6 | | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | Etfa , Etfb , Etfdh | | Colorectal Neoplasms | Acads | | Hypertension | Acsm3 | | Acidosis | Hadhb | | Short chain Acyl CoA dehydrogenase deficiency | Acads | | Insulin Resistance | Acsl1 | | Glomerulonephritis, IGA | Acsm3 | | Celiac Disease | Acadl | | Diabetes Mellitus, Experimental | Acsl6 , Hadh | | Ocular Hypertension | Acsm3 | | Myocardial Infarction | Hadh | | Rhabdomyolysis | Hadhb | | Overweight | Acsm3 | | Pericardial Effusion | Hadhb | | Starvation | Acsl1 | | Hepatitis C, Chronic | Cpt1a | | LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY | Hadha | | Trifunctional Protein Deficiency | Hadha , Hadhb | | Carnitine-Acylcarnitine Translocase Deficiency | Slc25a20 | | Carnitine Palmitoyltransferase II Deficiency, Late-Onset | Cpt2 | | Carnitine Palmitoyltransferase II Deficiency, Infantile | Cpt2 | | Carnitine Palmitoyltransferase II Deficiency, Lethal Neonatal | Cpt2 | | Mental Retardation, X-Linked 63 | Acsl4 | | Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of | Acad9 | |
|